Gazette Tracker
Gazette Tracker

Core Purpose

The National Pharmaceutical Pricing Authority fixes the retail prices, exclusive of Goods and Services Tax, for 37 specified drug formulations in exercise of powers under the Drugs (Prices Control) Order, 2013.

Detailed Summary

The Ministry of Chemicals and Fertilizers, Department of Pharmaceuticals, through the National Pharmaceutical Pricing Authority (NPPA), issued Notification S.O. 3563(E) on 1st August, 2025, to fix the retail prices for 37 specific drug formulations. This action is taken under paragraphs 5, 11, and 15 of the Drugs (Prices Control) Order, 2013, and in conjunction with S.O. 1394(E) dated 30th May, 2013, and S.O. 5249(E) dated 11th November, 2022. The notification specifies the retail price per unit, exclusive of Goods and Services Tax, for each formulation, along with its strength, unit, and the manufacturer/marketing company. Examples of fixed prices include Aceclofenac, Paracetamol & Trypsin Chymotrypsin Tablets at Rs. 13.00 and Rs. 15.01, Amoxycillin & Potassium Clavulanate Oral suspension at Rs. 3.32 per ml, Atorvastatin & Clopidogrel Tablets at Rs. 25.61, Empagliflozin, Linagliptin & Metformin Hydrochloride (Extended Release) Tablets at Rs. 33.13, and Diclofenac Injection at Rs. 31.77 per ml. Manufacturers of these 'new drug' formulations, as defined under paragraph 2(1)(u) of DPCO, 2013, must adhere to these prices, may add GST if applicable, and are required to issue a price list in Form-V to NPPA via IPDMS and State Drug Controllers as per paragraph 24 of DPCO, 2013. Retailers and dealers must display this price list as per paragraph 24(4) of DPCO, 2013. Non-compliance will result in liability to deposit overcharged amounts with interest under the DPCO, 2013, read with the Essential Commodities Act, 1955. This notification supersedes any prior price orders for the specified formulations and companies. The notification was signed by Mahaveer Saini, Dy. Director, and referenced as PN/267/135/2025/F /F. No. 8(135)/2025/D.P./NPPA-Div.-II.

Full Text

REGD. No. D. L.-33004/99 The Gazette of India CG-DL-E-01082025-265167 EXTRAORDINARY PART II-Section 3-Sub-section (ii) PUBLISHED BY AUTHORITY No. 3477] NEW DELHI, FRIDAY, AUGUST 1, 2025/SHRAVANA 10, 1947 MINISTRY OF CHEMICALS AND FERTILIZERS (Department of Pharmaceuticals) (NATIONAL PHARMACEUTICAL PRICING AUTHORITY) NOTIFICATION New Delhi, the 1st August, 2025 S.O. 3563(E). In exercise of the powers conferred by paragraphs 5, 11 and 15 of the Drugs (Prices Control) Order, 2013, read with S.O. 1394(E) dated the 30th May, 2013 and S.O. 5249(E) dated 11th November, 2022 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority (hereinafter referred as NPPA) hereby fixes, the price as specified in column (6) of the table herein below as the retail price, exclusive of Goods and Services Tax, if any, in relation to the formulation specified in the corresponding entry in column (2) of the said Table with the strength, unit and name of manufacturer & marketing company, as specified in the corresponding entries in columns (3), (4) and (5) thereof; TABLE +-----+----------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------+----------------------------------------------+--------------------+ | SI. | Medicines | Strength | Unit | Manufacturer & Marketing Company | Retail Price (Rs.) | | No. | | | | | | +-----+----------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------+----------------------------------------------+--------------------+ | (1) | (2) | (3) | (4) | (5) | (6) | +-----+----------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------+----------------------------------------------+--------------------+ | 1 | Aceclofenac, Paracetamol & | Each enteric coated tablet contains: Proteolytic enzymes Trypsin & Chymotrypsin in the ratio of Approximately 6:1 and provides enzymatic activity Eq. to 1,50,000 Armour units Aceclofenac IP 100 mg Paracetamol IP 325 mg | 1 Tablet | M/s Akums Drugs & Pharmaceuticals Ltd./ | 13.00 | | | Trypsin Chymotrypsin Tablets | | | M/s Dr. Reddy's Laboratories Ltd. | | +-----+----------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------+----------------------------------------------+--------------------+ | 2 | Aceclofenac, Paracetamol & | Each enteric coated tablet contains: Proteolytic enzymes Trypsin & Chymotrypsin in the ratio of Approximately 6:1 and provides enzymatic activity Eq. to 1,50,000 Armour units Aceclofenac IP 100 mg Paracetamol IP 325 mg | 1 Tablet | M/s Akums Drugs & Pharmaceuticals Ltd./ | 15.01 | | | Trypsin Chymotrypsin Tablets | | | M/s Cadila Pharmaceuticals Ltd. | | +-----+----------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------+----------------------------------------------+--------------------+ | 3 | Amoxycillin & Potassium | Each 5 ml of reconstituted suspension contains: Amoxycillin Trihydrate IP equivalent to Amoxycillin 600 mg Potassium Clavulanate Diluted IP equivalent to Clavulanic Acid 42.9 mg | 1 ml | M/s Copmed Pharmaceuticals Pvt. Ltd./ | 3.32 | | | Clavulanate Oral suspension | | | M/s Zydus Healthcare Ltd. | | +-----+----------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------+----------------------------------------------+--------------------+ | 4 | Atorvastatin & Clopidogrel Tablets | Each uncoated bilayered tablet contains: Atorvastatin Calcium IP Equivalent to Atorvastatin 40 mg Clopidogrel Bisulphate IP equivalent to Clopidogrel 75 mg | 1 Tablet | M/s Pure and Cure Healthcare Pvt. Ltd./ | 25.61 | | | | | | M/s Lupin Ltd. | | +-----+----------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------+----------------------------------------------+--------------------+ | 5 | Atorvastatin & Ezetimibe Tablets | Each Film Coated Tablet Contains: Atorvastatin Calcium IP Eq. to Atorvastatin 10 mg Ezetimibe IP 10 mg | 1 Tablet | M/s Pure and Cure Healthcare Pvt. Ltd./ | 19.86 | | | | | | M/s Cadila Pharmaceuticals Ltd. | | +-----+----------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------+----------------------------------------------+--------------------+ | 6 | Atorvastatin & Ezetimibe Tablets | Each Film Coated Tablet Contains: Atorvastatin Calcium IP Eq. to Atorvastatin 20 mg Ezetimibe IP 10 mg | 1 Tablet | M/s Pure and Cure Healthcare Pvt. Ltd./ | 30.10 | | | | | | M/s Cadila Pharmaceuticals Ltd. | | +-----+----------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------+----------------------------------------------+--------------------+ | 7 | Atorvastatin & Ezetimibe Tablets | Each Film Coated Tablet Contains: Atorvastatin Calcium IP Eq. to Atorvastatin 40 mg Ezetimibe IP 10 mg | 1 Tablet | M/s Pure and Cure Healthcare Pvt. Ltd./ | 30.47 | | | | | | M/s Cadila Pharmaceuticals Ltd. | | +-----+----------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------+----------------------------------------------+--------------------+ | 8 | Atorvastatin Calcium and | Each hard gelatin capsule contains: Atorvastatin Calcium IP equivalent to Atorvastatin 10mg (As pellets) Clopidogrel Bisulphate IP equivalent to Clopidogrel 75mg (As pellets) | 1 Capsule | M/s Synokem Pharmaceuticals Ltd./ | 15.94 | | | Clopidogrel Capsules | | | M/s Alkem Laboratories Ltd. | | +-----+----------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------+----------------------------------------------+--------------------+ | 9 | Atorvastatin, Clopidogrel and | Each hard gelatin capsule contains: Atorvastatin Calcium IP Eqv. to Atorvastatin 10 mg (As Pellets) Clopidogrel Bisulphate IP Eq. to Clopidogrel 75 mg (As Pellets) Aspirin IP 75 mg (As enteric coated Pellets) | 1 Capsule | M/s Synokem Pharmaceuticals Ltd./ | 5.88 | | | Aspirin Capsules | | | M/s Aristo Laboratories Pvt. Ltd. | | +-----+----------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------+----------------------------------------------+--------------------+ | 10 | Atorvastatin, Clopidogrel and | Each hard gelatin capsule contains: Atorvastatin Calcium IP Eqv. to Atorvastatin 20 mg (As Pellets) Clopidogrel Bisulphate IP | 1 Capsule | M/s Synokem Pharmaceuticals Ltd./ | 8.33 | | | Aspirin Capsules | Eq. to Clopidogrel 75 mg (As Pellets) Aspirin IP 75 mg (As enteric coated Pellets) | | M/s Aristo Laboratories Pvt. Ltd. | | +-----+----------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------+----------------------------------------------+--------------------+ | 11 | Bilastine & Montelukast Tablet | Each film coated bilayered tablet contains: Bilastine IP 40 mg Montelukast Sodium IP eq. to Montelukast 10 mg | 1 Tablet | M/s Akums Drugs & Pharmaceuticals Ltd./ | 22.78 | | | | | | M/s Lupin Ltd. | | +-----+----------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------+----------------------------------------------+--------------------+ | 12 | Bisoprolol Fumarate & Amlodipine | Each film coated tablet contains: Bisoprolol Fumarate IP 2.5 mg Amlodipine Besylate IP equivalent to Amlodipine 5 mg | 1 Tablet | M/s Swiss Garnier Life Sciences/ | 6.70 | | | Tablets | | | M/s Cadila Pharmaceuticals Ltd. | | +-----+----------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------+----------------------------------------------+--------------------+ | 13 | Cefixime Oral Suspension | One Combipack contains: Part (A) Each 5ml of reconstituted suspension contains: Cefixime IP equivalent to Cefixime Anhydrous 200 mg Part (B) Each ampoule contains Sterile Water for Injection IP 25ml | 1 ml | M/s Alps Communication Pvt. Ltd./ | 3.72 | | | (Combipack) | | | M/s Aristo Pharmaceuticals Pvt. Ltd. | | +-----+----------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------+----------------------------------------------+--------------------+ | 14 | Cefixime, Dicloxacillin (CR) | Each film coated tablet contains: Cefixime IP as Trihydrate Eq. to Anhydrous Cefixime 200mg Dicloxacillin Sodium IP Eq. to Dicloxacillin 500 mg (Controlled release) Lactic Acid Bacillus 2.5 Billion Spores (Appropriate Overages of Lactic Acid Bacillus Spores Added) | 1 Tablet | M/s Akums Drugs & Pharmaceuticals Ltd. / | 15.25 | | | and Lactic Acid Bacillus Tablets | | | M/s Alkem Laboratories Ltd. | | +-----+----------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------+----------------------------------------------+--------------------+ | 15 | Cholecalciferol Oral Drops | Each ml contains: Cholecalciferol (Vitamin D3) IP 800 IU (as Stabilized) | 1 ml | M/s Ravenbhel Biotech/ | 6.11 | | | | | | M/s Zydus Healthcare Ltd. | | +-----+----------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------+----------------------------------------------+--------------------+ | 16 | Cilnidipine & Telmisartan Tablets | Each film coated tablet contains: Cilnidipine IP 20 mg Telmisartan IP 40 mg | 1 Tablet | M/s Akums Drugs & Pharmaceuticals Ltd./ | 14.51 | | | | | | M/s Lupin Ltd. | | +-----+----------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------+----------------------------------------------+--------------------+ | 17 | Diclofenac Sodium, | Each uncoated tablet contains: Diclofenac Sodium IP 50 mg Paracetamol IP 325 mg Chlorzoxazone USP 250 mg | 1 Tablet | M/s Innova Captab Ltd./ | 6.03 | | | Paracetamol & Chlorzoxazone | | | M/s Dr. Reddys Laboratories Ltd. | | | | Tablets | | | | | +-----+----------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------+----------------------------------------------+--------------------+ | 18 | Escitalopram Oxalate & | Each Film Coated Tablet Contains: Escitalopram Oxalate IP eq.to Escitalopram 5 mg Clonazepam IP 0.25 mg | 1 Tablet | M/s Pure and Cure Healthcare Pvt. Ltd./ | 8.38 | | | Clonazepam Tablets | | | M/s Abbott Healthcare Pvt. Ltd. | | +-----+----------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------+----------------------------------------------+--------------------+ | 19 | Paracetamol, Phenylephrine | Each uncoated tablet contains: Paracetamol IP 500 mg Phenylephrine Hydrochloride IP 10 mg Chlorpheniramine Maleate IP 2 mg | 1 Tablet | M/s East African (I) Overseas | 5.15 | | | Hydrochloride & Chlorpheniramine | | | /M/s Troikaa Pharmaceuticals Ltd. | | | | Maleate Tablets | | | | | +-----+----------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------+----------------------------------------------+--------------------+ | 20 | Empagliflozin, Linagliptin & | Each film coated bilayer tablet contains: Empagliflozin 25 mg Linagliptin 5 mg Metformin Hydrochloride IP 1000 mg (as extended release) | 1 Tablet | M/s Exemed Pharmaceuticals / M/s Corona Remedies Pvt. Ltd. | 33.13 | | | Metformin Hydrochloride | | | | | | | (Extended Release) Tablets | | | | | +-----+----------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------+----------------------------------------------+--------------------+ | 21 | Empagliflozin, Sitagliptin & | Each film coated bilayer tablet contains: Empagliflozin 25 mg Sitagliptin Phosphate Monohydrate IP equivalent to Sitagliptin 100 mg Metformin Hydrochloride IP 1000 mg (as extended release) | 1 Tablet | M/s Exemed Pharmaceuticals / M/s USV Ltd. | 27.50 | | | Metformin Hydrochloride | | | | | | | (Extended Release) Tablets | | | | | +-----+----------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------+----------------------------------------------+--------------------+ | 22 | Empagliflozin, Sitagliptin & | Each film coated bilayer tablet contains: Empagliflozin 25 mg Sitagliptin Phosphate Monohydrate IP equivalent to Sitagliptin 100 mg Metformin Hydrochloride IP 1000 mg (as extended release) | 1 Tablet | M/s Exemed Pharmaceuticals / M/s Micro Labs Ltd. | 16.50 | | | Metformin Hydrochloride | | | | | | | (Extended Release) Tablets | | | | | +-----+----------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------+----------------------------------------------+--------------------+ | 23 | Empagliflozin, Sitagliptin & | Each film coated bilayer tablet contains: Empagliflozin 25 mg Sitagliptin Phosphate Monohydrate IP equivalent to Sitagliptin 100 mg Metformin Hydrochloride IP 1000 mg (as extended release) | 1 Tablet | M/s Exemed Pharmaceuticals/ M/s Aristo Pharmaceuticals Pvt. Ltd. | 17.42 | | | Metformin Hydrochloride | | | | | | | (Extended Release) Tablets | | | | | +-----+----------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------+----------------------------------------------+--------------------+ | 24 | Empagliflozin, Sitagliptin & | Each film coated bilayer tablet contains: Empagliflozin 10 mg Sitagliptin Phosphate Monohydrate IP equivalent to Sitagliptin 100 mg Metformin Hydrochloride IP 1000 mg (as extended release) | 1 Tablet | M/s Exemed Pharmaceuticals/ M/s Aristo Pharmaceuticals Pvt. Ltd. | 14.74 | | | Metformin Hydrochloride | | | | | | | (Extended Release) Tablets | | | | | +-----+----------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------+----------------------------------------------+--------------------+ | 25 | Empagliflozin & Metformin | Each film coated tablet contains: Empagliflozin 12.5 mg Metformin Hydrochloride IP 500 mg | 1 Tablet | M/s Pure and Cure Healthcare Pvt. Ltd./ | 18.70 | | | Hydrochloride Tablets | | | M/s Eris Lifesciences Ltd. | | +-----+----------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------+----------------------------------------------+--------------------+ | 26 | Empagliflozin & Metformin | Each film coated tablet contains: Empagliflozin 12.5 mg Metformin Hydrochloride IP 500 mg | 1 Tablet | M/s Windlas Biotech Ltd./ M/s Medley Pharmaceuticals Ltd. | 13.40 | | | Hydrochloride Tablets | | | | | +-----+----------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------+----------------------------------------------+--------------------+ | 27 | Empagliflozin & Metformin | Each film coated tablet contains: Empagliflozin 12.5 mg Metformin Hydrochloride IP 1000 mg | 1 Tablet | M/s Windlas Biotech Ltd./ M/s Medley Pharmaceuticals Ltd. | 14.30 | | | Hydrochloride Tablets | | | | | +-----+----------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------+----------------------------------------------+--------------------+ | 28 | Sitagliptin + Pioglitazone + | Each film coated bilayered tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 100mg Pioglitazone Hydrochloride IP eq. to Pioglitazone 15mg Metformin Hydrochloride IP (as sustained release form) 500mg | 1 Tablet | M/s Akums Drugs & Pharmaceuticals Ltd./ | 14.11 | | | Metformin Hydrochloride | | | M/s Workcell Solutions Pvt. Ltd. | | | | (Sustained Release) Tablets | | | | | +-----+----------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------+----------------------------------------------+--------------------+ | 29 | Sitagliptin, Glimepiride & | Each film coated bilayered tablet contains: Sitagliptin Phosphate Monohydrate IP 64.25 mg equivalent to Sitagliptin 50 mg Glimepiride IP 1 mg Metformin Hydrochloride IP 1000 mg | 1 Tablet | M/s Tristar Formulations Pvt. Ltd/ | 11.16 | | | Metformin Hydrochloride Tablets | | | M/s Franco Indian Pharmaceuticals Pvt. Ltd. | | +-----+----------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------+----------------------------------------------+--------------------+ | 30 | Sitagliptin, Glimepiride & | Each film coated bilayered tablet contains: Sitagliptin Phosphate Monohydrate IP 64.25 mg equivalent to Sitagliptin 50 mg Glimepiride IP 2 mg Metformin Hydrochloride IP 1000 mg | 1 Tablet | M/s Tristar Formulations Pvt. Ltd/ | 12.59 | | | Metformin Hydrochloride Tablets | | | M/s Franco Indian Pharmaceuticals Pvt. Ltd. | | +-----+----------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------+----------------------------------------------+--------------------+ | 31 | Sitagliptin, Glimepiride & | Each film coated bilayered tablet contains: Sitagliptin Phosphate Monohydrate IP equivalent to Sitagliptin 50mg Glimepiride IP 1 mg Metformin Hydrochloride IP 500mg | 1 Tablet | M/s Exemed Pharmaceuticals/ M/s Primus Remedies Pvt. Ltd. | 12.19 | | | Metformin Hydrochloride Tablets | | | | | +-----+----------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------+----------------------------------------------+--------------------+ | 32 | Sitagliptin, Glimepiride & | Each film coated bilayered tablet contains: Sitagliptin Phosphate Monohydrate IP equivalent to Sitagliptin 50mg Glimepiride IP 1 mg Metformin Hydrochloride IP 500mg | 1 Tablet | M/s Exemed Pharmaceuticals/ M/s Aristo Pharmaceuticals Pvt. Ltd. | 11.52 | | | Metformin Hydrochloride Tablets | | | | | +-----+----------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------+----------------------------------------------+--------------------+ | 33 | Sitagliptin, Glimepiride & | Each film coated bilayered tablet contains: Sitagliptin Phosphate Monohydrate IP equivalent to Sitagliptin 50mg Glimepiride IP 2 mg Metformin Hydrochloride IP 500mg | 1 Tablet | M/s Exemed Pharmaceuticals/ M/s Primus Remedies Pvt. Ltd. | 13.87 | | | Metformin Hydrochloride Tablets | | | | | +-----+----------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------+----------------------------------------------+--------------------+ | 34 | Sitagliptin, Glimepiride & | Each film coated bilayered tablet contains: Sitagliptin Phosphate Monohydrate IP equivalent to Sitagliptin 50mg Glimepiride IP 2 mg Metformin Hydrochloride IP 500mg | 1 Tablet | M/s Exemed Pharmaceuticals/ M/s Aristo Pharmaceuticals Pvt. Ltd. | 14.69 | | | Metformin Hydrochloride Tablets | | | | | +-----+----------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------+----------------------------------------------+--------------------+ | 35 | Paracetamol, Phenylephrine HCl, | Each 5 ml contains: Paracetamol IP 250 mg Phenylephrine Hydrochloride IP 5 mg Chlorpheniramine Maleate IP 2 mg | 1 ml | M/s Res-Sancta Limited / M/s Biological E. Limited | 0.71 | | | Chlorpheniramine Maleate suspension | | | | | +-----+----------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------+----------------------------------------------+--------------------+ | 36 | Paracetamol, Phenylephrine HCl, | Each 5ml (teaspoonful) contains: Paracetamol IP 250 mg Phenylephrine Hydrochloride IP 5 mg Chlorpheniramine Maleate IP 2 mg Ammonium Chloride IP 120 mg Sodium Citrate IP 60 mg Menthol IP 1 mg | 1 ml | M/s Windlas Biotech Limited / M/s Biological E. Limited | 0.41 | | | Chlorpheniramine Maleate, | | | | | | | Ammonium Chloride, Sodium | | | | | | | Citrate & Menthol suspension | | | | | +-----+----------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------+----------------------------------------------+--------------------+ | 37 | Diclofenac Injection | Each ml contains: Diclofenac Sodium IP 75 mg | 1ml | M/s Nitin Lifesciences Ltd. /M/s. Mankind Prime Labs Pvt. Ltd. | 31.77 | +-----+----------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------+----------------------------------------------+--------------------+ Note: (a) The manufacturer of above-mentioned formulations i.e., โ€œnew drugโ€ under paragraph 2(1)(u) of the DPCO, 2013 shall fix the retail price as specified in column (6) of the table hereinabove. (b) The manufacturer may add Goods and Services Tax only if they have paid actually or it is payable to the Government on the retail price mentioned in column (6) of the above said table. (c) The retail price for a pack of the aforesaid formulation shall be arrived at by the concerned manufacturer in accordance with the retail price specified in column (6) of the above table as per provisions contained in paragraph 11 of the DPCO, 2013. The manufacturer shall issue a price list in Form-V from date of Notification as per paragraph 24 of the DPCO, 2013 to NPPA through IPDMS and submit a copy to State Drug Controller and dealers. (d) As per para 24(4) of DPCO 2013, every retailer and dealer shall display price list and the supplementary price list, if any, as furnished by the manufacturer, on a conspicuous part of the premises where he carries on business in a manner so as to be easily accessible to any person wishing to consult the same. (e) The above mentioned retail price is applicable only to the individual manufacturer / marketer as mentioned above i.e. who have applied for the same by submitting Form-I for price fixation / revision as stipulated under DPCO, 2013 and subject to fulfilment of all the applicable statutory requirements as laid down by the Govt. under relevant statutes/rules, including manufacturing license permission from the Competent Authority i.e. the Central/State Licensing Authority, as may be applicable, by the concerned manufacturer/marketing companies. (f) In case the retail price of any of the aforesaid formulations is not complied with, as per instant price notification and notes specified hereinabove, then the concerned manufacturer/marketing company shall be liable to deposit the overcharged amount along with the interest thereon under the provisions of the DPCO, 2013 read with the Essential Commodities Act, 1955. (g) Consequent to the fixation of retail price of such formulation as specified in column (2) of the above table with the strength and name of Manufacturer & Marketing Companies specified in the corresponding entries in Column (3) & (5) thereof, the price order(s) fixing the retail price of the formulation with specified strength for that Manufacturer & Marketing Companies as specified in corresponding entries in Column (2), (3) and (5) thereof, if any, issued prior to this notification, stand(s) superseded. [PN/267/135/2025/F /F. No. 8(135)/2025/D.P./NPPA-Div.-II] MAHAVEER SAINI, Dy. Director Uploaded by Dte. of Printing at Government of India Press, Ring Road, Mayapuri, New Delhi-110064 and Published by the Controller of Publications, Delhi-110054.

Never miss important gazettes

Create a free account to save gazettes, add notes, and get email alerts for keywords you care about.

Sign Up Free